What is the ticker symbol for Neuphoria Therapeutics?

Neuphoria Therapeutics trades under the ticker NEUP on NASDAQ.

What sector does Neuphoria Therapeutics operate in?

Neuphoria Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze NEUP in a portfolio?

PortView shows NEUP's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Neuphoria Therapeutics (NEUP) Stock Analysis

NASDAQHealthcareBiotechnology

$3.39-0.07%

1-year price historyRange $3.24 – $5.48

52-week range$3.39

$3.19$5.53

Track NEUP in your portfolio for free · Portfolio tracker

What Neuphoria Therapeutics does

Neuphoria Therapeutics Inc., a clinical stage biopharmaceutical company, develops novel allosteric ion channel modulators for patients with serious central nervous system disorders in Australia. Its lead product candidate is BNC210, an oral, proprietary, selective negative allosteric modulator of the alpha7 nicotinic acetylcholine receptor for post-traumatic stress disorder. The company also develops Merck alpha7 positive allosteric modulators. It has a research collaboration and license agreement with Merck & Co., Inc. to develop alpha7 receptor positive allosteric modulators targeting cognitive dysfunction associated with Alzheimer's disease and other central nervous system conditions. The company was formerly known as Bionomics Limited and changed its name to Neuphoria Therapeutics Inc. in December 2024. Neuphoria Therapeutics Inc. was incorporated in 1996 and is based in Millis, Massachusetts.

Key metrics

Market cap

$18.33M

P/E (TTM)

-0.31

EPS (TTM)

$-11.06

Beta

0.75

Dividend yield

0.00%

Revenue / share

$0.22

50-day avg

$3.62

200-day avg

$4.18

52-week high

$5.53

52-week low

$3.19

CEO

Spyridon Papapetropoulos

ETFs linked to NEUP

Broad-market and Healthcare sector ETFs an investor holding Neuphoria Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how NEUP fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze NEUP in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Neuphoria Therapeutics?: Neuphoria Therapeutics trades under the ticker NEUP on NASDAQ.
Which exchange is NEUP listed on?: NEUP is listed on NASDAQ.
What sector does Neuphoria Therapeutics operate in?: Neuphoria Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze NEUP in a portfolio?: PortView shows NEUP's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.